Dr. Noah Davidsohn—Gene Therapies for Age-Related Diseases

1

Introduction

00:00 • 2min

2

MIT Bioengineering - What Drives You to Be a Scientist?

01:39 • 2min

3

Gene Therapy - What Inspired You to Start a Company?

03:11 • 2min

4

Epigenetics and Gene Therapy

05:03 • 2min

5

The Yamanaka Factors

06:46 • 3min

6

Is There a Safety Factor in Stem Cells?

09:34 • 2min

7

Can Yamunaka Factors Reverse Aging?

11:56 • 3min

8

Induce the Yamanaka Factors to a Long Girl?

14:29 • 3min

9

Is AAV Associated With Age Related Diseases?

17:12 • 2min

10

Rejuvenate Bio

19:19 • 3min

11

FGF21 and GGF-Beta1 - What's the Difference?

22:40 • 2min

12

Is There a Target for RJBO2?

24:43 • 2min

13

Gene Therapy for Dogs - Why Are You Going in Parallel?

27:13 • 2min

14

The Next Indication for FGF21 in Dogs and Humans?

29:16 • 2min

15

Taking Genes From the Longevity Field and Creating Therapies From Them

31:11 • 2min

16

Is It Practical to Still Go After Aging Without Proper Biomarkers?

33:05 • 2min

17

Gene Therapy

34:48 • 2min

18

Do You Have a Gene Therapy for Dogs?

36:34 • 4min